{
    "organizations": [],
    "uuid": "24a203587accfa83b02e3eb916d2d6be1bc54975",
    "author": "",
    "url": "https://www.reuters.com/article/brief-teligent-inc-announces-fda-approva/brief-teligent-inc-announces-fda-approval-of-halobetasol-propionate-ointment-0-05-idUSASC09T5O",
    "ord_in_thread": 0,
    "title": "BRIEF-Teligent, Inc. Announces FDA Approval Of Halobetasol Propionate Ointment, 0.05%",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 46 PM / Updated 11 minutes ago BRIEF-Teligent, Inc. Announces FDA Approval Of Halobetasol Propionate Ointment, 0.05% Reuters Staff March 21 (Reuters) - Teligent Inc: * TELIGENT, INC. ANNOUNCES FDA APPROVAL OF HALOBETASOL PROPIONATE OINTMENT, 0.05% * TELIGENT INC - EXPECT TO LAUNCH HALOBETASOL PROPIONATE OINTMENT, 0.05% IN Q2 OF 2018 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)",
    "published": "2018-03-21T14:45:00.000+02:00",
    "crawled": "2018-03-21T14:58:57.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "fda",
        "approval",
        "halobetasol",
        "propionate",
        "ointment",
        "reuters",
        "staff",
        "march",
        "reuters",
        "teligent",
        "inc",
        "teligent",
        "announces",
        "fda",
        "approval",
        "halobetasol",
        "propionate",
        "ointment",
        "teligent",
        "inc",
        "expect",
        "launch",
        "halobetasol",
        "propionate",
        "ointment",
        "q2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}